CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis through the miR-455-3p/NUPR1/FTH1 axis, with NUPR1 inhibition sensitizing HCC cells to lenvatinib. This evidence concerns the gene FTH1 and hepatocellular carcinoma.